SLC2A3 and colorectal cancer: A study on colorectal carcinoma also underscored that upregulation of the SLC2A3 gene was associated with decreased overall and disease-free survival in patients with colorectal cancer, suggesting that determination of SLC2A3 expression might be useful for predicting the prognosis of these patients (Kim et al., 2019).